Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study

(2017) Annalisa Berzigotti et al.   HEPATOLOGY

Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats

(2016) Prasanthi Jegatheesan et al.   BRITISH JOURNAL OF NUTRITION

A Diet Combining High Fat and Glucose-Fructose Syrup Induces Obesity, Non-Alcoholic Steatohepatitis and Portal Hypertension in a New Animal Model

(2016) T. García-Lezana et al.   JOURNAL OF HEPATOLOGY

Gut microorganisms as promising targets for the management of type 2 diabetes

(2015) Nathalie M. Delzenne et al.   DIABETOLOGIA

Attenuated portal hypertension in germ-free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vessels

(2015) Sheida Moghadamrad et al.   HEPATOLOGY

Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity

(2015) Frank J. Gonzalez et al.   JOURNAL OF HEPATOLOGY

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

(2015) Sungsoon Fang et al.   NATURE MEDICINE

Interactions Between the Intestinal Microbiome and Liver Diseases

(2014) Bernd Schnabl et al.   GASTROENTEROLOGY

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

(2014) Changtao Jiang et al.   JOURNAL OF CLINICAL INVESTIGATION

Microbiota-liver axis in hepatic disease

(2013) Benoit Chassaing et al.   HEPATOLOGY

Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats

(2013) Len Verbeke et al.   HEPATOLOGY

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

(2013) Samuele De Minicis et al.   HEPATOLOGY

Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice

(2013) V. K. Ridaura et al.   SCIENCE

Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

(2012) Flavia D. Mendes et al.   Clinical Gastroenterology and Hepatology

Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome

(2012) Anne Vrieze et al.   GASTROENTEROLOGY

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

(2012) Tiphaine Le Roy et al.   GUT

Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction

(2012) Vincenzo La Mura et al.   HEPATOLOGY

The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins

(2012) Giusi Marrone et al.   JOURNAL OF HEPATOLOGY

Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture

(2012) Sven Francque et al.   LABORATORY INVESTIGATION

Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD

(2012) Marcos Pasarín et al.   PLoS One

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

(2011) Annalisa Berzigotti et al.   HEPATOLOGY

Insulin resistance and liver microcirculation in a rat model of early NAFLD

(2011) Marcos Pasarín et al.   JOURNAL OF HEPATOLOGY

Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension

(2010) S Francque et al.   INTERNATIONAL JOURNAL OF OBESITY

Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulationin vitroandin vivoin a rat model

(2009) Sven Francque et al.   LIVER INTERNATIONAL

Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo

(2008) E. R. Duncan et al.   DIABETES